Nordhealth Balance Sheet Health

Financial Health criteria checks 6/6

Nordhealth has a total shareholder equity of €82.8M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €91.9M and €9.2M respectively.

Key information

0%

Debt to equity ratio

€0

Debt

Interest coverage ration/a
Cash€22.17m
Equity€82.77m
Total liabilities€9.17m
Total assets€91.94m

Recent financial health updates

Recent updates

Nordhealth AS' (OB:NORDH) 25% Jump Shows Its Popularity With Investors

Apr 10
Nordhealth AS' (OB:NORDH) 25% Jump Shows Its Popularity With Investors

What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Feb 23
What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Jan 03
Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

May 12
Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Jan 25
Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Financial Position Analysis

Short Term Liabilities: NORDH's short term assets (€28.4M) exceed its short term liabilities (€9.0M).

Long Term Liabilities: NORDH's short term assets (€28.4M) exceed its long term liabilities (€136.0K).


Debt to Equity History and Analysis

Debt Level: NORDH is debt free.

Reducing Debt: NORDH has no debt compared to 5 years ago when its debt to equity ratio was 2.5%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NORDH has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: NORDH has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 81.6% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.